Exelixis, Inc.

EXEL Healthcare
$42.28 $-0.38 (-0.89%)
Market Cap: $11.38 B
Gurus Holding
10
Popularity Rank
#397
% of Shares Held
9.91%
Net Activity (Q3 2025)
+$83.91 M

Guru Ownership Trend

Guru Analysis for Exelixis, Inc. (EXEL)

Exelixis, Inc. (EXEL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.13 B.

Top institutional holders include Renaissance Technologies and Cliff Asness.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $83.91 M net inflow during the quarter.

Recent activity highlights Ray Dalio who dramatically increased their stake. Conversely, Paul Tudor Jones reduced exposure by 23.8%.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.84% Reduce -2.3% 15,459,266 $638.47 M Q3 2025
0.24% Add 20.7% 9,181,359 $379.19 M Q3 2025
0.14% Add 3940.1% 842,965 $34.81 M Q3 2025
0.15% Reduce -1.4% 834,018 $34.44 M Q3 2025
0.94% 105,000 $4.34 M Q3 2025
0.02% Add 30.2% 97,624 $4.03 M Q3 2025
0.01% Reduce -23.8% 80,359 $3.32 M Q3 2025
0.00% Add 4.4% 46,812 $1.93 M Q3 2025
0.00% Reduce -21.3% 16,271 $671,992 Q3 2025
0.00% New Buy 11,849 $489,364 Q3 2025

Key Holders

Top 5 by Value

$379.19 M
$34.81 M
$34.44 M
$4.34 M

Top 5 by Conviction

Recent Activity Breakdown (Q3 2025)

+$100.52 M
Total Buy Value
New Buys 1
Additions 4
-$16.61 M
Total Sell Value
Reductions 4
Sold Out 0

Guru Consensus (Q3 2025)

Based on recent activity
Net Sellers
4
Net Buyers
5

FAQs for Exelixis, Inc. (EXEL)

Major holders include Renaissance Technologies ($638.47 M), Cliff Asness ($379.19 M), Ray Dalio ($34.81 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 26.68 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $83.91 M, with 5 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited EXEL. The total reported sell value was $16.61 M.

Yes, 1 managers opened new positions in EXEL, and 4 increased their existing holdings. The total reported buy value was $100.52 M.